MoonLake Immunotherapeutics (MLTX)
NASDAQ
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | Mr. Matthias BodenstedtCFO | -13.65k | 273.33k | Automatic Disposition | 20.02 | 1.17M | -1.15% |
| 2026-04-14 | Mr. Matthias BodenstedtCFO | -2.43k | 47.45k | Automatic Disposition | 19.56 | 1.19M | -0.20% |
| 2026-04-10 | Dr. Jorge Santos da SilvaCo-Founder, Interim Chair of the Board & CEO | -150.00k | 2.75M | 売り | 18.23 - 18.41 | 2.92M | -4.88% |
| 2026-04-09 | Mr. Matthias BodenstedtCFO | -87.80k | 1.66M | Automatic Disposition | 18.94 - 19.51 | 1.19M | -6.88% |
| 2026-03-31 | BVF Partners L.P.法人 | -3.75M | 62.96M | 売り | 16.79 | 15.94M | -19.04% |
| 2025-12-19 | Mr. Matthias BodenstedtCFO | 294.47k | 0.00 | Derivative Exercise and Retained Stock | - | 922.01k | 46.93% |
| 2025-12-19 | Mr. Matthias BodenstedtCFO | -294.47k | 0.00 | Sale to Issuer | - | 0.00 | -100.00% |
| 2025-12-19 | Dr. Kristian ReichCo-Founder & Chief Scientific Officer | 35.39k | 0.00 | Derivative Exercise and Retained Stock | - | 3.01M | 1.19% |
| 2025-12-19 | Dr. Kristian ReichCo-Founder & Chief Scientific Officer | -35.39k | 0.00 | Sale to Issuer | - | 0.00 | -100.00% |
| 2025-12-19 | Dr. Jorge Santos da SilvaCo-Founder, Interim Chair of the Board & CEO | 196.32k | 0.00 | Derivative Exercise and Retained Stock | - | 3.07M | 6.82% |
| 2025-12-19 | Dr. Jorge Santos da SilvaCo-Founder, Interim Chair of the Board & CEO | -196.32k | 0.00 | Sale to Issuer | - | 0.00 | -100.00% |
| 2025-12-08 | Dr. Jorge Santos da SilvaCo-Founder, Interim Chair of the Board & CEO | -200.00k | 2.97M | 売り | 14.49 - 15.08 | 2.88M | -6.50% |
| 2025-12-08 | Dr. Kristian ReichCo-Founder & Chief Scientific Officer | -202.91k | 3.01M | 売り | 14.43 - 15.08 | 2.97M | -6.39% |
| 2025-10-08 | Mr. Matthias BodenstedtCFO | 10.87k | 98.81k | 買い | 9.09 | 627.54k | 1.76% |
| 2025-09-29 | Cormorant Asset Management, LP法人 | -2.81M | 18.55M | 売り | 6.61 - 6.96 | 1.99M | -58.45% |
| 2025-09-29 | Cormorant Asset Management, LP法人 | -3.69M | 28.32M | 売り | 7.58 - 9.38 | 1.99M | -64.94% |
| 2025-09-02 | Dr. Kristian ReichCo-Founder & Chief Scientific Officer | 48.98k | 0.00 | Derivative Exercise and Retained Stock | - | 3.18M | 1.57% |
| 2025-09-02 | Dr. Kristian ReichCo-Founder & Chief Scientific Officer | -48.98k | 0.00 | Sale to Issuer | - | 35.39k | -58.05% |
| 2025-07-03 | Mrs. Catherine MoukheibirIndependent Director | -23.50k | 1.15M | Derivative Exercise and Sale | 48.79 | 0.00 | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。